Alignment Healthcare, Inc. (ALHC) stock
Close on Nov 18, 2026Market cap $1.41BP/E 61.1Yield –
Earnings
Alignment Healthcare's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.
Quarterly results
Revenue and earnings per share from each of Alignment Healthcare's earnings releases, newest first
| Quarter | Reported | Revenue | YoY | EPS | Source |
|---|---|---|---|---|---|
| Q4 FY2026ended Dec 31, 2026 | Feb 25, 2027Expected | – | – | – | – |
| Q3 FY2026ended Sep 30, 2026 | Oct 29, 2026after the close | $1.36B | +36.7% | -$0.04 | Release |
| Q2 FY2026ended Jun 30, 2026 | Jul 30, 2026after the close | $1.34B | +31.5% | $0.17 | Release |
| Q1 FY2026ended Mar 31, 2026 | Apr 30, 2026after the close | $1.24B | +33.3% | $0.05 | Release |
| Q4 FY2025ended Dec 31, 2025 | Feb 26, 2026after the close | $1.01B | +44.4% | – | Release |
| Q3 FY2025ended Sep 30, 2025 | Oct 30, 2025after the close | $993.70M | – | $0.02 | Release |
| Q2 FY2025ended Jun 30, 2025 | Jul 30, 2025after the close | $1.02B | +49.0% | $0.07 | Release |
| Q1 FY2025ended Mar 31, 2025 | May 1, 2025after the close | $926.90M | +47.5% | – | Release |
| Q4 FY2024ended Dec 31, 2024 | Feb 27, 2025after the close | $701.20M | +50.7% | – | Release |
| Q3 FY2024ended Sep 30, 2024 | Oct 29, 2024after the close | – | – | – | Release |
| Q2 FY2024ended Jun 30, 2024 | Aug 1, 2024after the close | $681.30M | +47.3% | -$0.13 | Release |
| Q1 FY2024ended Mar 31, 2024 | May 2, 2024after the close | $628.60M | +43.1% | -$0.25 | Release |
| Q4 FY2023ended Dec 31, 2023 | Feb 27, 2024after the close | $465.40M | +28.6% | -$0.25 | Release |
| Q3 FY2023ended Sep 30, 2023 | Nov 2, 2023after the close | $456.70M | +26.8% | -$0.19 | Release |
| Q2 FY2023ended Jun 30, 2023 | Aug 3, 2023after the close | $462.40M | +26.2% | -$0.15 | Release |
| Q1 FY2023ended Mar 31, 2023 | May 4, 2023after the close | $439.20M | +27.1% | -$0.20 | Release |
| Q4 FY2022ended Dec 31, 2022 | Feb 28, 2023after the close | $361.80M | +21.3% | -$0.31 | Release |
| Q3 FY2022ended Sep 30, 2022 | Nov 3, 2022after the close | $360.30M | +22.8% | -$0.22 | Release |
| Q2 FY2022ended Jun 30, 2022 | Aug 4, 2022after the close | $366.50M | – | -$0.06 | Release |
| Q1 FY2022ended Mar 31, 2022 | May 5, 2022after the close | $345.50M | – | -$0.23 | Release |
| Q4 FY2021ended Dec 31, 2021 | Mar 3, 2022after the close | $298.30M | – | -$0.27 | Release |
| Q3 FY2021ended Sep 30, 2021 | Nov 4, 2021after the close | $293.50M | – | -$0.26 | Release |
| Q2 FY2021ended Jun 30, 2021 | Aug 9, 2021after the close | – | – | – | Filing |
| Q1 FY2021ended Mar 31, 2021 | May 17, 2021after the close | – | – | – | Filing |
Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.
Current guidance
Alignment Healthcare's latest outlook for periods it has not reported yet, compared with what it said before
| Metric | Period | Guidance | Before | Change | Given |
|---|---|---|---|---|---|
| RevenueGAAP | Q4 FY2026 | $1.32B | – | New | Oct 29, 2026 |
| Adjusted EBITDAnon-GAAP | Q4 FY2026 | -$28.00M | – | New | Oct 29, 2026 |
| Adjusted Gross Profitnon-GAAP | Q4 FY2026 | $104.00M | – | New | Oct 29, 2026 |
| Health Plan Membership | Q4 FY2026 | 305,000 | – | New | Oct 29, 2026 |
| RevenueGAAP | FY2026 | $5.25B | – | New | Oct 29, 2026 |
| Revenue | FY2026 | $5.16B – $5.21B | – | New | Apr 30, 2026 |
| Adjusted EBITDAnon-GAAP | FY2026 | $100.00M | – | New | Oct 29, 2026 |
| Adjusted EBITDAnon-GAAP | FY2026 | $138.00M – $163.00M | – | New | Apr 30, 2026 |
| Adjusted Gross Profitnon-GAAP | FY2026 | $575.00M | – | New | Oct 29, 2026 |
| Adjusted Gross Profitnon-GAAP | FY2026 | $620.00M – $650.00M | – | New | Apr 30, 2026 |
| Health Plan Membership | FY2026 | 305,000 | – | New | Oct 29, 2026 |
| Health Plan Membership | FY2026 | 294,000 – 299,000 | – | New | Apr 30, 2026 |
Guidance vs results
The last range Alignment Healthcare gave before each report, against the figure it then reported. Full years add up the four quarters.
| Period | Metric | Guidance | Actual | Result |
|---|---|---|---|---|
| Q3 FY2026 | Revenue | $1.30B – $1.32B | $1.36B | Above range |
| Q2 FY2026 | Revenue | $1.30B – $1.32B | $1.34B | Above range |
| FY2025 | Revenue | $3.93B – $3.95B | $3.95BΣ4Q | Above range |
| Q4 FY2025 | Revenue | $995.00M – $1.01B | $1.01B | Above range |
| Q3 FY2025 | Revenue | $970.00M – $985.00M | $993.70M | Above range |
| Q1 FY2025 | Revenue | $880.00M – $895.00M | $926.90M | Above range |
| Q2 FY2024 | Revenue | $625.00M – $635.00M | $681.30M | Above range |
| Q1 FY2024 | Revenue | $590.00M – $600.00M | $628.60M | Above range |
| Q4 FY2023 | Revenue | $422.00M – $442.00M | $465.40M | Above range |
| Q3 FY2023 | Revenue | $440.00M – $445.00M | $456.70M | Above range |
| Q2 FY2023 | Revenue | $433.00M – $438.00M | $462.40M | Above range |
| Q1 FY2023 | Revenue | $429.00M – $434.00M | $439.20M | Above range |
| Q4 FY2022 | Revenue | $338.00M – $343.00M | $361.80M | Above range |
| Q3 FY2022 | Revenue | $330.00M – $335.00M | $360.30M | Above range |
| Q2 FY2022 | Revenue | $335.00M – $340.00M | $366.50M | Above range |
| Q1 FY2022 | Revenue | $330.00M – $335.00M | $345.50M | Above range |
| Q4 FY2021 | Revenue | $265.00M – $270.00M | $298.30M | Above range |
Guidance history
Every forecast Alignment Healthcare put in an earnings release, newest first
| Given | Metric | Period | Guidance | Change |
|---|---|---|---|---|
| Oct 29, 2026 | Adjusted EBITDA | Q4 FY2026 | -$28.00M | New |
| Oct 29, 2026 | Adjusted EBITDA | FY2026 | $100.00M | New |
| Oct 29, 2026 | Health Plan Membership | Q4 FY2026 | 305,000 | New |
| Oct 29, 2026 | Adjusted Gross Profit | Q4 FY2026 | $104.00M | New |
| Oct 29, 2026 | Health Plan Membership | FY2026 | 305,000 | New |
| Oct 29, 2026 | Adjusted Gross Profit | FY2026 | $575.00M | New |
| Oct 29, 2026 | Revenue | Q4 FY2026 | $1.32B | New |
| Oct 29, 2026 | Revenue | FY2026 | $5.25B | New |
| Jul 30, 2026 | Adjusted EBITDA | Q3 FY2026 | $20.00M – $30.00M | New |
| Jul 30, 2026 | Health Plan Membership | Q3 FY2026 | 295,500 – 297,500 | New |
| Jul 30, 2026 | Adjusted Gross Profit | Q3 FY2026 | $148.00M – $158.00M | New |
| Jul 30, 2026 | Revenue | Q3 FY2026 | $1.30B – $1.32B | New |
| Apr 30, 2026 | Adjusted EBITDA | FY2026 | $138.00M – $163.00M | New |
| Apr 30, 2026 | Adjusted EBITDA | Q2 FY2026 | $50.00M – $60.00M | New |
| Apr 30, 2026 | Health Plan Membership | FY2026 | 294,000 – 299,000 | New |
| Apr 30, 2026 | Adjusted Gross Profit | FY2026 | $620.00M – $650.00M | New |
| Apr 30, 2026 | Health Plan Membership | Q2 FY2026 | 288,000 – 290,000 | New |
| Apr 30, 2026 | Adjusted Gross Profit | Q2 FY2026 | $167.00M – $177.00M | New |
| Apr 30, 2026 | Revenue | FY2026 | $5.16B – $5.21B | New |
| Apr 30, 2026 | Revenue | Q2 FY2026 | $1.30B – $1.32B | New |
| Oct 30, 2025 | Adjusted EBITDA (1) | FY2025 | $90.00M – $98.00M | New |
| Oct 30, 2025 | Adjusted EBITDA (1) | Q4 FY2025 | -$9.00M – -$1.00M | New |
| Oct 30, 2025 | Health Plan Membership | FY2025 | 232,500 – 234,500 | New |
| Oct 30, 2025 | Adjusted Gross Profit (1) | FY2025 | $474.00M – $483.00M | New |
| Oct 30, 2025 | Health Plan Membership | Q4 FY2025 | 232,500 – 234,500 | New |
| Oct 30, 2025 | Adjusted Gross Profit (1) | Q4 FY2025 | $104.00M – $113.00M | New |
| Oct 30, 2025 | Revenue | FY2025 | $3.93B – $3.95B | New |
| Oct 30, 2025 | Revenue | Q4 FY2025 | $995.00M – $1.01B | New |
| Jul 30, 2025 | Adjusted EBITDA | Q3 FY2025 | $5.00M – $13.00M | New |
| Jul 30, 2025 | Adjusted EBITDA | FY2025 | $69.00M – $83.00M | New |
| Jul 30, 2025 | Health Plan Membership | Q3 FY2025 | 225,000 – 227,000 | New |
| Jul 30, 2025 | Adjusted Gross Profit | Q3 FY2025 | $106.00M – $114.00M | New |
| Jul 30, 2025 | Health Plan Membership | FY2025 | 229,000 – 234,000 | New |
| Jul 30, 2025 | Adjusted Gross Profit | FY2025 | $452.00M – $469.00M | New |
| Jul 30, 2025 | Revenue | Q3 FY2025 | $970.00M – $985.00M | New |
| Jul 30, 2025 | Revenue | FY2025 | $3.89B – $3.91B | New |
| Feb 27, 2025 | Adjusted EBITDA | Q1 FY2025 | $2.00M – $10.00M | New |
| Feb 27, 2025 | Adjusted Gross Profit | Q1 FY2025 | $89.00M – $97.00M | New |
| Feb 27, 2025 | Health Plan Membership | Q1 FY2025 | 211,000 – 215,000 | New |
| Feb 27, 2025 | Revenue | Q1 FY2025 | $880.00M – $895.00M | New |
| Aug 1, 2024 | Adjusted EBITDA(2) | FY2024 | -$12.00M – $12.00M | Reaffirmed |
| Aug 1, 2024 | Adjusted Gross Profit(1) | Q3 FY2024 | $75.00M – $81.00M | New |
| Aug 1, 2024 | Adjusted Gross Profit(1) | FY2024 | $280.00M – $310.00M | New |
| Aug 1, 2024 | Health Plan Membership | Q3 FY2024 | 176,000 – 178,000 | New |
| Aug 1, 2024 | Health Plan Membership | FY2024 | 178,000 – 180,000 | Raised |
| Aug 1, 2024 | Revenue | Q3 FY2024 | $655.00M – $665.00M | New |
| Aug 1, 2024 | Revenue | FY2024 | $2.61B – $2.64B | Raised |
| May 2, 2024 | Adjusted EBITDA | Q2 FY2024 | $0 – $6.00M | New |
| May 2, 2024 | Adjusted EBITDA | FY2024 | -$12.00M – $12.00M | Narrowed |
| May 2, 2024 | Health Plan Membership | Q2 FY2024 | 167,000 – 169,000 | New |
| May 2, 2024 | Health Plan Membership | FY2024 | 170,000 – 172,000 | Raised |
| May 2, 2024 | Adjusted Gross Profit | FY2024 | $280.00M – $310.00M | Raised |
| May 2, 2024 | Adjusted Gross Profit | Q2 FY2024 | $71.00M – $77.00M | New |
| May 2, 2024 | Revenue | FY2024 | $2.50B – $2.53B | Raised |
| May 2, 2024 | Revenue | Q2 FY2024 | $625.00M – $635.00M | New |
| Feb 27, 2024 | Adjusted EBITDA | Q1 FY2024 | -$19.00M – -$13.00M | New |
| Feb 27, 2024 | Adjusted EBITDA | FY2024 | -$15.00M – $15.00M | New |
| Feb 27, 2024 | Health Plan Membership | Q1 FY2024 | 157,000 – 159,000 | New |
| Feb 27, 2024 | Adjusted Gross Profit | Q1 FY2024 | $52.00M – $58.00M | New |
| Feb 27, 2024 | Health Plan Membership | FY2024 | 162,000 – 164,000 | New |
| Feb 27, 2024 | Adjusted Gross Profit | FY2024 | $275.00M – $310.00M | New |
| Feb 27, 2024 | Revenue | Q1 FY2024 | $590.00M – $600.00M | New |
| Feb 27, 2024 | Revenue | FY2024 | $2.38B – $2.41B | New |
| Nov 2, 2023 | Adjusted EBITDA | Q4 FY2023 | -$18.00M – -$10.00M | New |
| Nov 2, 2023 | Adjusted EBITDA | FY2023 | -$34.00M – -$26.00M | Lowered |
| Nov 2, 2023 | Adjusted Gross Profit | Q4 FY2023 | $46.00M – $54.00M | New |
| Nov 2, 2023 | Adjusted Gross Profit | FY2023 | $206.00M – $214.00M | Narrowed |
| Nov 2, 2023 | Health Plan Membership | Q4 FY2023 | 117,600 – 118,600 | New |
| Nov 2, 2023 | Health Plan Membership | FY2023 | 117,600 – 118,600 | Raised |
| Nov 2, 2023 | Revenue | Q4 FY2023 | $422.00M – $442.00M | New |
| Nov 2, 2023 | Revenue | FY2023 | $1.78B – $1.80B | Raised |
| Aug 3, 2023 | Adjusted EBITDA | Q3 FY2023 | -$12.00M – -$9.00M | New |
| Aug 3, 2023 | Adjusted EBITDA | FY2023 | -$34.00M – -$20.00M | Reaffirmed |
| Aug 3, 2023 | Adjusted Gross Profit | Q3 FY2023 | $54.00M – $57.00M | New |
| Aug 3, 2023 | Adjusted Gross Profit | FY2023 | $205.00M – $217.00M | Reaffirmed |
| Aug 3, 2023 | Health Plan Membership | Q3 FY2023 | 113,500 – 113,700 | New |
| Aug 3, 2023 | Health Plan Membership | FY2023 | 113,500 – 115,500 | Raised |
| Aug 3, 2023 | Revenue | Q3 FY2023 | $440.00M – $445.00M | New |
| Aug 3, 2023 | Revenue | FY2023 | $1.76B – $1.79B | Raised |
| May 4, 2023 | Adjusted EBITDA | Q2 FY2023 | -$13.00M – -$10.00M | New |
| May 4, 2023 | Adjusted EBITDA | FY2023 | -$34.00M – -$20.00M | Reaffirmed |
| May 4, 2023 | Adjusted Gross Profit | FY2023 | $205.00M – $217.00M | New |
| May 4, 2023 | Adjusted Gross Profit | Q2 FY2023 | $47.00M – $50.00M | New |
| May 4, 2023 | Health Plan Membership | Q2 FY2023 | 111,200 – 111,400 | New |
| May 4, 2023 | Health Plan Membership | FY2023 | 113,000 – 115,000 | Reaffirmed |
| May 4, 2023 | Revenue | Q2 FY2023 | $433.00M – $438.00M | New |
| May 4, 2023 | Revenue | FY2023 | $1.71B – $1.74B | Raised |
| Feb 28, 2023 | Adjusted EBITDA | Q1 FY2023 | -$17.00M – -$14.00M | New |
| Feb 28, 2023 | Adjusted EBITDA | FY2023 | -$34.00M – -$20.00M | New |
| Feb 28, 2023 | Health Plan Membership | Q1 FY2023 | 109,300 – 109,500 | New |
| Feb 28, 2023 | Adjusted Gross Profit | Q1 FY2023 | $38.00M – $41.00M | New |
| Feb 28, 2023 | Health Plan Membership | FY2023 | 113,000 – 115,000 | New |
| Feb 28, 2023 | Adjusted Gross Profit | FY2023 | $205.00M – $217.00M | New |
| Feb 28, 2023 | Revenue | Q1 FY2023 | $429.00M – $434.00M | New |
| Feb 28, 2023 | Revenue | FY2023 | $1.71B – $1.73B | New |
| Nov 3, 2022 | Adjusted EBITDA | Q4 FY2022 | -$30.00M – -$27.00M | New |
| Nov 3, 2022 | Adjusted EBITDA | FY2022 | -$33.00M – -$30.00M | Raised |
| Nov 3, 2022 | Adjusted Gross Profit | Q4 FY2022 | $34.00M – $37.00M | New |
| Nov 3, 2022 | Adjusted Gross Profit | FY2022 | $189.00M – $192.00M | Raised |
| Nov 3, 2022 | Health Plan Membership | Q4 FY2022 | 98,000 – 99,000 | New |
| Nov 3, 2022 | Health Plan Membership | FY2022 | 98,000 – 99,000 | Raised |
| Nov 3, 2022 | Revenue | Q4 FY2022 | $338.00M – $343.00M | New |
| Nov 3, 2022 | Revenue | FY2022 | $1.41B – $1.42B | Raised |
| Aug 4, 2022 | Adjusted EBITDA | Q3 FY2022 | -$23.00M – -$20.00M | New |
| Aug 4, 2022 | Adjusted EBITDA | FY2022 | -$41.00M – -$35.00M | Raised |
| Aug 4, 2022 | Health Plan Membership | Q3 FY2022 | 97,100 – 97,300 | New |
| Aug 4, 2022 | Adjusted Gross Profit | Q3 FY2022 | $38.00M – $40.00M | New |
| Aug 4, 2022 | Health Plan Membership | FY2022 | 97,300 – 99,000 | Reaffirmed |
| Aug 4, 2022 | Adjusted Gross Profit | FY2022 | $177.00M – $184.00M | New |
| Aug 4, 2022 | Revenue | Q3 FY2022 | $330.00M – $335.00M | New |
| Aug 4, 2022 | Revenue | FY2022 | $1.37B – $1.38B | New |
| May 5, 2022 | Adjusted EBITDA | Q2 FY2022 | -$11.00M – -$8.00M | New |
| May 5, 2022 | Adjusted EBITDA | FY2022 | -$46.00M – -$39.00M | Raised |
| May 5, 2022 | Adjusted Gross Profit | Q2 FY2022 | $41.00M – $43.00M | New |
| May 5, 2022 | Adjusted Gross Profit | FY2022 | $165.00M – $174.00M | Raised |
| May 5, 2022 | Health Plan Membership | Q2 FY2022 | 95,500 – 95,700 | New |
| May 5, 2022 | Health Plan Membership | FY2022 | 97,300 – 99,000 | Reaffirmed |
| May 5, 2022 | Revenue | Q2 FY2022 | $335.00M – $340.00M | New |
| May 5, 2022 | Revenue | FY2022 | $1.34B – $1.35B | Raised |
| Mar 3, 2022 | Adjusted EBITDA 2 | Q1 FY2022 | -$17.00M – -$13.00M | New |
| Mar 3, 2022 | Adjusted EBITDA 2 | FY2022 | -$47.00M – -$39.00M | New |
| Mar 3, 2022 | Adjusted Gross Profit 1 | Q1 FY2022 | $32.00M – $35.00M | New |
| Mar 3, 2022 | Adjusted Gross Profit 1 | FY2022 | $163.00M – $173.00M | New |
| Mar 3, 2022 | Health Plan Membership | Q1 FY2022 | 93,700 – 93,900 | New |
| Mar 3, 2022 | Health Plan Membership | FY2022 | 97,300 – 99,000 | New |
| Mar 3, 2022 | Revenue | Q1 FY2022 | $330.00M – $335.00M | New |
| Mar 3, 2022 | Revenue | FY2022 | $1.33B – $1.35B | New |
| Nov 4, 2021 | Adjusted EBITDA | Q4 FY2021 | -$30.00M – -$25.00M | New |
| Nov 4, 2021 | Adjusted EBITDA | FY2021 | -$54.00M – -$49.00M | New |
| Nov 4, 2021 | Adjusted Gross Profit | Q4 FY2021 | $24.00M – $28.00M | New |
| Nov 4, 2021 | Adjusted Gross Profit | FY2021 | $126.00M – $130.00M | New |
| Nov 4, 2021 | Health Plan Membership | Q4 FY2021 | 86,100 – 86,300 | New |
| Nov 4, 2021 | Health Plan Membership | FY2021 | 86,100 – 86,300 | New |
| Nov 4, 2021 | Revenue | Q4 FY2021 | $265.00M – $270.00M | New |
| Nov 4, 2021 | Revenue | FY2021 | $1.14B – $1.14B | New |
Read from the company's earnings releases; each figure links to its sentence on hover. “Raised” and “Lowered” compare with the previous range for the same metric and period.
Press releases
Releases Alignment Healthcare filed with the SEC as exhibits to Form 8-K or 6-K
- Results
- Results
- Update
- Results
- Results
- Update
- Update
- Results
- Results
- Results
- Results
- Update
- Update
- Update
- Results
See a number that looks wrong?